Immunogenicity testing of therapeutic antibodies in ocular fluids after intravitreal injection

被引:17
作者
Wessels, Uwe [1 ]
Zadak, Markus [1 ]
Reiser, Astrid [1 ]
Brockhaus, Janis [2 ]
Ritter, Mirko [2 ]
Abdolzade-Bavil, Afsaneh [1 ]
Heinrich, Julia [1 ]
Stubenrauch, Kay [1 ]
机构
[1] Roche Innovat Ctr Munich, Pharma Res & Early Dev, Pharmaceut Sci, Nonnenwald 2, D-82377 Penzberg, Germany
[2] Roche Diagnost GmbH, Roche Innovat Ctr Munich, Nonnenwald 2, D-82377 Penzberg, Germany
关键词
antidrug antibody; aqueous humor; drug tolerance; ELISA; immune complex assay; immunogenicity; ophthalmology; safety assessment; vitreous humor; DRUG TOLERANCE; BIOTECHNOLOGY PRODUCTS; MACULAR DEGENERATION; TARGET INTERFERENCE; VITREOUS-HUMOR; SERUM SAMPLES; ASSAYS; RECOMMENDATIONS; PHARMACOKINETICS; RANIBIZUMAB;
D O I
10.4155/bio-2018-0047
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Aim: High drug concentrations in ocular fluids after intravitreal administration preclude the use of drugsensitive immunoassays. A drug-tolerant immunoassay is therefore desirable for immunogenicity testing in ophthalmology. Experimental: Immune complex (IC) antidrug antibody (ADA) assays were established for two species. The assays were compared with the bridging assay in ocular and plasma samples from two preclinical studies. Results: The IC assays showed high drug tolerance, which enabled a reliable ADA detection in ocular fluids after intravitreal administration. The IC assays were superior to the bridging assay in the analysis of ocular fluids with high drug concentrations. Conclusion: The IC assay allows a reliable ADA detection in matrices with high drug concentrations, such as ocular fluids.
引用
收藏
页码:803 / 814
页数:12
相关论文
共 50 条
[41]   A First-Passage Model of Intravitreal Drug Delivery and Residence Time-Influence of Ocular Geometry, Individual Variability, and Injection Location [J].
Lamirande, Patricia ;
Gaffney, Eamonn A. ;
Gertz, Michael ;
Maini, Philip K. ;
Crawshaw, Jessica R. ;
Caruso, Antonello .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (12)
[42]   Duration of Vascular Endothelial Growth Factor Suppression After Intravitreal Injection of Brolucizumab and Aflibercept in Macaque Eyes [J].
Obata, Shumpei ;
Kakinoki, Masashi ;
Sawada, Osamu ;
Kawamoto, Ikuo ;
Murase, Mitsuru ;
Ohji, Masahito .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2023, 39 (03) :225-228
[43]   Lack of Therapeutic Effect of Ranibizumab in Fellow Eyes After Intravitreal Administration [J].
Gamulescu, Maria-Andreea ;
Helbig, Horst .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2010, 26 (02) :213-216
[44]   Internalization of therapeutic antibodies into dendritic cells as a risk factor for immunogenicity [J].
Siegel, Michel ;
Bolender, Anna-Lena ;
Ducret, Axel ;
Fraidling, Johannes ;
Hartman, Katharina ;
Looney, Cary M. ;
Rohr, Olivier ;
Hickling, Timothy P. ;
Kettenberger, Hubert ;
Lechmann, Martin ;
Marban-Doran, Celine ;
Kraft, Thomas E. .
FRONTIERS IN IMMUNOLOGY, 2024, 15
[45]   Vascular endothelial growth factor concentration in vitreous humor of patients with severe proliferative diabetic retinopathy after intravitreal injection of conbercept as an adjunctive therapy for vitrectomy [J].
Li Bing ;
Li Meng-Da ;
Ye Jun-Jie ;
Chen Zhe ;
Guo Zi-Jian ;
Di Yu .
CHINESE MEDICAL JOURNAL, 2020, 133 (06) :664-669
[46]   Ocular Hypertension and Intraocular Pressure Asymmetry After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents [J].
Pershing, Suzann ;
Bakri, Sophie J. ;
Moshfeghi, Darius M. .
OPHTHALMIC SURGERY LASERS & IMAGING, 2013, 44 (05) :460-464
[47]   Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration [J].
Claro, Carmen ;
Ruiz, Rosa ;
Cordero, Elisa ;
Pastor, M. Teresa ;
Lopez-Cortes, Luis Fernando ;
Jimenez-Castellanos, M. Rosa ;
Lucero, M. Jesus .
EXPERIMENTAL EYE RESEARCH, 2009, 88 (03) :528-534
[48]   Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes [J].
Yi, N. Y. ;
Davis, J. L. ;
Salmon, J. H. ;
Gilger, B. C. .
VETERINARY OPHTHALMOLOGY, 2008, 11 :15-19
[49]   Intravitreal Injection of Sulfamethoxazole and Trimethoprim Associated with Dexamethasone as an Alternative Therapy for Ocular Toxoplasmosis [J].
Souza, Carlos E. ;
Nascimento, Heloisa ;
Lima, Acacio ;
Muccioli, Cristina ;
Belfort, Rubens, Jr. .
OCULAR IMMUNOLOGY AND INFLAMMATION, 2018, 26 (07) :1041-1044
[50]   Intravitreal injection of bevacizumab: changes in intraocular pressure related to ocular axial length [J].
Cacciamani, Andrea ;
Oddone, Francesco ;
Parravano, Mariacristina ;
Scarinci, Fabio ;
Di Nicola, Marta ;
Lofoco, Giorgio .
JAPANESE JOURNAL OF OPHTHALMOLOGY, 2013, 57 (01) :63-67